Flerie AB (publ) (STO:FLERIE)

Sweden flag Sweden · Delayed Price · Currency is SEK
42.95
+1.25 (3.00%)
May 9, 2025, 5:29 PM CET
-21.62%
Market Cap 3.35B
Revenue (ttm) 400.00K
Net Income (ttm) -329.50M
Shares Out 78.07M
EPS (ttm) -4.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 120,913
Average Volume 40,507
Open 41.70
Previous Close 41.70
Day's Range 41.45 - 43.00
52-Week Range 37.21 - 57.00
Beta n/a
RSI 60.52
Earnings Date Apr 23, 2025

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol FLERIE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.